Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice
BMC Developmental Biology volume 11, Article number: 60 (2011)
Valuable insights into the complex process of retinal vascular development can be gained using models with abnormal retinal vasculature. Two such models are the recently described mouse lines with mutations in Lama1, an important component of the retinal internal limiting membrane (ILM). These mutants have a persistence of the fetal vasculature of vitreous (FVV) but lack a primary retinal vascular plexus. The present study provides a detailed analysis of astrocyte and vascular development in these Lama1 mutants.
Although astrocytes and blood vessels initially migrate into Lama1 mutant retinas, both traverse the peripapillary ILM into the vitreous by P3. Once in the vitreous, blood vessels anastomose with vessels of the vasa hyaloidea propria, part of the FVV, and eventually re-enter the retina where they dive to form the inner and outer retinal capillary networks. Astrocytes continue proliferating within the vitreous to form a dense mesh that resembles epiretinal membranes associated with persistent fetal vasculature and proliferative vitreoretinopathy.
Lama1 and a fully intact ILM are required for normal retinal vascular development. Mutations in Lama1 allow developing retinal vessels to enter the vitreous where they anastomose with vessels of the hyaloid system which persist and expand. Together, these vessels branch into the retina to form fairly normal inner retinal vascular capillary plexi. The Lama1 mutants described in this report are potential models for studying the human conditions persistent fetal vasculature and proliferative vitreoretinopathy.
The retinal vasculature, which nourishes the inner retina, consists of three plexi: the superficial in the nerve fiber layer, the intermediate in the inner plexiform layer, and the deep in the outer plexiform layer. The photoreceptors in the outer retina are maintained by the choroidal vessels. Retinal vessels develop in man during fetal development  but in mice during the first 3 post-natal weeks . Prior to the formation of retinal vessels, the lens and developing inner retina are nourished by the hyaloid vasculature. This three component vasculature (hyaloid artery, vasa hyaloidea propria, and tunica vasculosa lentis) lies in the vitreous, a gel-like structure separating the retina and the lens. The hyaloid vessels regress as retinal vessels form and are gone in humans by birth and by three weeks in the mouse. The portion of the hyaloid vasculature closest to the retina is the vasa hyaloidea propria (VHP) which is also the last to regress.
Although occurring prior to birth in the human and post-natally in the mouse, the retinal vasculature develops in a similar pattern in these species. The primary vascular plexus forms first and, once complete, branching vessels dive into the inner retina to form the deep plexus and then the intermediate plexus (Figure 1). The stimuli guiding the formation of retinal vessels, has yet to be confirmed. While in the mouse retina, endothelial cells migrate and proliferate across the retina guided by an astrocyte template [2, 3], other guidance systems determine the pattern in dog  and man [5–7]. Furthermore, many studies have pointed towards VEGF as a key regulator in vascular development [8, 9], but it has recently been demonstrated that retinal vessels form normally without astrocyte-derived VEGF . Together, these data suggest that other proteins and, potentially, cells other than astrocytes guide endothelial cell migration in forming the superficial retinal vasculature.
The proximity of the internal limiting membrane (ILM) to retinal astrocytes and the superficial vasculature suggests that this structure may be important for development of retinal blood vessels. Indeed, several mouse mutants with disruptions to the ILM have an abnormal retinal vasculature [11–14]. Laminin α1 is a primary component of laminin 111, which is believed to be important for basement membrane formation [15–18]. In addition, this laminin chain links the ILM to receptors, such as integrins and dystroglycan , which are found on Müller cells in the retina [20, 21]. Retinal vascular defects have recently been described in two mouse lines with mutations in Lama1, the gene which encodes laminin α1 . While the vascular defects are similar, the two mutants differ in their generation and effect on laminin α1, one being a recessive point mutation (Lama1nmf223 ) and the other being a conditional knockout that leads to the complete loss of Lama1 (Lama1tm1.Olf , herein referred to as Lama1Δ) but bypasses the embryonic lethality normally associated with laminin α1 deletion. In the Lama1nmf223 mice, a chemically-induced mutation causes the replacement of a tyrosine with a cysteine at amino acid 265 (Y265C) in the N-terminal domain, which includes sites for receptors binding as well as polymerization . Here forward, Lama1nmf223 and Lama1Δ refer to mice homozygous for the respective mutations.
The present study investigates the development of retinal vessels in the previously described Lama1 mutants. Focus was placed on the Lama1nmf223 because a random point mutation has greater potential to be associated with human disease than the complete deletion of Lama1, which is embryonic lethal in mice [15, 22] and likely to cause lethality in humans as well. The observation that a point mutation in this large gene causes retinal disease in mice suggests that it may also do so in humans. Transmission electron microscopy (TEM) was used for ultrastructural analysis of the ILM, glial cells, and blood vessels in these mice. Finally, epiretinal membranes are described in both of these mutants that have characteristics similar to human persistent fetal vasculature (PFV) and proliferative vitreoretinopathy (PVR).
Retinal vessels form in the Lama1nmf223retina at P1
Blood vessel and astrocyte development was first investigated in cross sections by labeling with anti-pan laminin, anti-platelet-derived growth factor receptor α (PDGFRα) and GS isolectin at postnatal day (P) 1 when the primary retinal vasculature has just begun to form. In the wild type (WT) retina, astrocytes and blood vessels extended from the optic nerve head under the laminin-positive ILM (Figure 2A-D). Although some astrocytes were also observed along the base of the hyaloid artery, the vast majority of these glial cells were observed under the ILM. No astrocytes were observed in the vitreous away from the hyaloid artery. In the Lama1nmf223 sections, blood vessels and PDGFRα-positive astrocytes were observed on the retinal side of the ILM in the peripapillary region, the area surrounding the optic nerve head (Figure 2E-H). Adjacent to this region, however, astrocytes were observed traversing the ILM into the vitreous (Figure 2E-L). In addition, some sections demonstrated astrocytes migrating into the vitreous along the hyaloid vessels (shown later at P3). Sequential confocal Z stacks were used to evaluate these sections and revealed openings in the ILM through which astrocytes entered the vitreous (Figure 2I-L). Peripheral to these "break" points, astrocytes were observed in a linear arrangement on the vitreal aspect of the ILM and only an occasional astrocyte was observed in the retina (Figure 2I, K). Unlike those in the retina, vitreal astrocytes expressed laminin.
Flatmount WT retinas were labeled with fluorescein isothiocyanate conjugated Griffonia simplicifolia isolectin B4 (GS isolectin) to visualize blood vessels and anti-glial fibrillary acidic protein (GFAP) to visualize astrocytes. This labeling revealed a vascular apron surrounding the optic nerve head with endothelial cell filopodia extending out over an astrocyte template (Figure 3A). When present, hyaloid vessels were easily distinguished from those in the retina by the plane of focus and their GS isolectin intensity. A similar vascular apron was observed in Lama1nmf223 mice (Figure 3B). In addition, a number of individual GS isolectin positive cells were observed in both the WT and Lama1nmf223 retinas. Some of these cells are microglia, which GS isolectin also labels, as they also were positive for IBA-1 (data not shown).
JB-4 sections taken from WT eyes that were stained with periodic acid-Schiff (PAS) and hematoxylin revealed that all astrocytes were under the fully intact ILM (Figure 4A, B). JB-4 sections also demonstrated astrocytes leaving the retina in the peripapillary region of Lama1nmf223 mice (Figure 4C). Peripheral to this point, astrocytes were not observed in the retina (Figure 4D). Ultrastructure analysis with TEM confirmed that astrocytes migrate into the vitreous through openings/breaks in the ILM. Müller cell processes were also seen extending into the vitreous at these break points (Figure 4G). Although they express GFAP, the astrocytes in the vitreous have few, if any, well-defined intermediate filaments at this stage, demonstrating that they are still maturing (Figure 4E). The migration of astrocytes into the vitreous near the peripapillary region and on the hyaloid artery was observed consistently in all eyes examined with the different techniques.
Lama1nmf223retinal vessels migrate into the vitreous by P3
Examination of retinal flatmounts at P3 revealed the extension of blood vessels in the WT retina to the midperiphery behind a fully-formed astrocytic template (Figure 3D, E). The hyaloid vessels, which detached from the retina during dissection, were still present but were not ensheathed with retinal astrocytes (Figure 3F). Immunohistochemical labeling of cross sections demonstrated that retinal vessels and astrocytes were located on the retinal side of the ILM (Figure 5A-D). One or two astrocytes were observed along the hyaloid artery right at the optic nerve head (Figure 5D). Despite the close proximity of the VHP vessels to the ILM, they did not cross this barrier or make contact with retinal astrocytes in the WT eyes (Figure 5E-H). By contrast, the vessels in the Lama1nmf223 retinas had not progressed from that seen at P1 in retinal flatmounts (Figure 3C). There were also less astrocytes in the mutant retina (Figure 3H) compared to the WT (Figure 3E). A number of GS isolectin-positive cells were, however, observed throughout both the WT (Figure 3D, E) and Lama1nmf223 retinas (Figure 3C, G). These cells were more prominent in the avascular regions of both the WT and the Lama1nmf223 retinas. Imaging of retinas with the vitreous intact demonstrated that most of the Lama1nmf223 astrocytes had migrated into the vitreous where they invested the VHP (Figure 3G-I). Astrocytes were also observed forming thin glial bridges connecting blood vessels within the vitreous (Figure 3I). Capillary networks were seen branching from the Lama1nmf223 VHP (Figure 3G). As was observed at P1, cross sectional analysis revealed astrocytes migrating from the retina into the vitreous both at the optic nerve head and through breaks in the ILM (Figure 5I-P). These astrocytes extended in a linear fashion along the vitreal aspect of the ILM. At this stage, astrocytes were clearly enveloping VHP vessels and forming a laminin-positive membrane-like structure. The retinal vessels observed in the peripapillary region at P1 had also migrated into the vitreous. JB-4 cross sections demonstrated that these vessels had begun to anastomose with vessels of the VHP (Figure 4H-I).
Only intravitreal vessels are evident in Lama1nmf223mice at P7
At P7, the primary vascular plexus was complete in the WT retina with the exception of the extreme periphery in some retinas (Figure 6A-C). This vasculature included arteries and veins as well as the typical chicken wire-like capillary plexus. The astrocyte template was complete in WT mice at this stage with astrocytes ensheathing retinal vessels (Figure 6D-F). The hyaloid vasculature and VHP had begun regressing and detached easily from the retina during dissection. When present, these vessels had GS isolectin-positive cells, likely hyalocytes, on top of them (Figure 6A-C). By contrast, the Lama1nmf223 retinal vasculature resembled that of the P3 retina, being limited to an apron in the peripapillary region. Retinal vessels were absent beyond this point and individual GS isolectin-positive cells were prominent (Figure 6G-I). There was a large reduction in the number of astrocytes within the mutant retina (Figure 6G-I) compared to the control (Figure 6D-F). While some peripheral retinal astrocytes formed a normal honeycomb-like pattern, most extended long thin processes across the retina. When the vitreous was left intact, a much different image was revealed (Figure 6J-L). A large number of astrocytes were observed in the vitreous where they ensheathed vessels and formed a dense membrane-like structure. The intravitreal capillary networks, which had begun forming at P3, were more extensive. In sections, anti-pan laminin and GS isolectin labeling demonstrated the peripapillary retinal vessels traversing the ILM into the vitreous where they continued to extend towards ora serrata (Figure 7A-C). A membrane-like laminin positive structure was forming in association with these vitreal vessels (Figure 7A, C). Peripheral to break points in the ILM, no intraretinal vessels were observed (Figure 7A). It is important to note that the laminin-positive ILM was also observed on either side of blood vessels traversing into the vitreous (Figure 7B). Labeling of adjacent sections with anti-PDGFRα in addition to anti-pan laminin and GS isolectin revealed that astrocytes crossed the ILM and were part of the vitreal membrane (Figure 7D-E). These astrocytes were positive for laminin. These astrocytes extended along the vitreal side of the ILM and towards ora serrata in a fashion similar to that observed within the inner retina of the WT mice (data now shown).
Intravitreal vessels invade the Lama1nmf223 retina by P10
In the P10 WT retina, the superficial chicken wire capillary network was remodeled into a spoke-wheel-like system with an organized branching pattern (Figure 8A). Astrocytes had a distinct stellate morphology with thin processes that contacted and ensheathed retinal blood vessels (Figure 8A). Superficial vessels could be seen diving to form the deep capillary plexus (Figure 8B). GS isolectin labeling of the Lama1nmf223 flatmount retinas demonstrated an extensive vascular network with an unusual branching pattern in the vitreous (Figure 8C). When the vitreous was left intact and retinas double-labeled with GS isolectin and anti-GFAP, the appearance was similar to that at P7 although the astrocyte "membrane" appeared to be denser. At this stage, branches from intravitreal vessels extended into the retina to form an intraretinal capillary plexus (Figure 8D, E). This abnormal branching was best appreciated with confocal Z stack images through the retina (Figure 9 A-D). Labeling of whole eye cross sections with anti-PDGFRα, anti-pan laminin, and GS isolectin more clearly demonstrated vessels within the vitreous and their branches that had invaded the inner and outer retina and formed a capillary network in the outer plexiform layer (Figure 9E-H). In addition to astrocytes migrating near the vitreoretinal surface, some had migrated further into the vitreous (Figure 10 A-D). Many of these astrocytes possessed long, thin processes and created glial bridges between intravitreal blood vessels. JB-4 sections of the WT retina revealed that astrocytes resided under the ILM and that the superficial vessels were diving into the deeper retinal layers (Figure 11A, B). In the Lama1nmf223 P10 JB-4 sections, long thin processes from the glial bridges mentioned above as well as their frequent contact with blood vessels could be appreciated (Figure 11C). In some cases, they created tractional attachments with the vessels (Figure 11D). Astrocytes extended across the vitreal surface of the ILM to the far periphery. Some astrocytes appeared to have made contact with cells in the retina. Intravitreal vessels that had invaded the retina, extended into both the nerve fiber layer and into the deeper retina (Figure 9). Ultrastructural analysis demonstrated breaks in the ILM similar to those seen at P1 (data not shown). Astrocytes and blood vessels were closely associated in the vitreous (Figure 11E). Additionally, intermediate filaments were present in intravitreal astrocytes at this age (Figure 11F).
Fundus examination of four-week old Lama1nmf223 mice demonstrated a white membrane-like structure surrounding hyaloid vessels in the vitreal plane of focus, (Figure 12A). The position of this membrane in relation to the vitreal blood vessels suggested it was the astrocytic membrane observed in flatmounts and sectioned retinas. Fluorescein angiography confirmed the presence of large patent vessels within the vitreous (Figure 12B). These vessels could be seen branching into the retina to form the inner retinal capillary system. Flatmount retinas labeled with anti-GFAP and GS isolectin confirmed the continuance of the astrocyte membrane in the vitreous of Lama1nmf223 mutants (Figure 12C). Labeling with anti-PDGFRα, anti-pan laminin, and GS isolectin clearly showed a chain of PDGFRα-positive astrocytes across the vitreal surface of the ILM as well as the glial bridges between intravitreal blood vessels (Figure 12D, E). The vitreal vessels dove into the retina where they branched to form the inner and outer retinal capillary networks (Figure 12D, E).
Abnormal retinal vascular development in the Lama1Δ mice is similar to that in Lama1nmf223
Transmission electron microscopy revealed a double layered ILM which spanned the entire retina in the WT mouse at P1 (Figure 13A). By contrast, the P1 Lama1Δ mice revealed a thin, fragmented ILM that contained frequent breaks through which astrocytes, Müller cells, and ganglion cells seemed to be protruding (Figure 13B). Astrocytes were observed on the vitreal side of the ILM (Additional File 1, Fig. S1). The vascular development in Lama1Δ retinas was examined at key time points determined by investigation of the Lama1nmf223 mutants: P1, P7, and P10. At P1, a small apron of vessels was evident at the optic nerve head, similar to that seen in the Lama1nmf223 mutants (Figure 13C). When the vitreous was left intact, astrocytes were observed on the hyaloid vessels at P1. At P7, the GFAP and GS isolectin labeling produced images similar to those from the Lama1nmf223 mice showing astrocytes associating with the VHP (Figure 13D) and no vessels within the retina (Additional File 2, Fig. S2). Labeling of the P10 retina revealed a dense astrocyte network present in the vitreous of the Lama1Δ mice that was more dense than in the Lama1nmf223 eye (Figure 13E) and intravitreal vessels extending into the retina (Figure 13F). In some retinas, GFAP-positive processes were also observed traversing the retina along with the blood vessels. The deep vasculature was developing from diving vitreal vessels at P10 (Figure 13G). In summary, the same changes occurred in the Lama1Δ mice as in the Lama1nmf223 mice. The progression, however, was slightly faster and the severity of the pathology was greater at least in terms of astrocyte coverage of the VHP.
The previous study reported that few, if any, retinal vessels developed in the Lama1 mutants and that these were replaced by persistent intravitreal vessels which penetrate the retina to form the intraretinal capillary networks . Using confocal microscopy, additional immunohistochemical markers, cross sectional analysis, and TEM, the present study redefines the development of retinal vessels and astrocytes in the Lama1 mutants. In addition, the previously described "vitreal fibroplasia" is identified as a vitreal membrane containing laminin-positive astrocytes, similar to human persistent fetal vasculature.
The ILM in the Lama1nmf223 retina is normal in appearance throughout much of the retina but has small frequent breaks. By contrast, the Lama1Δ mice have a very thin ILM with a diffuse, nonlinear appearance throughout much of the retina. In addition, breaks in the Lama1Δ retina generally extended over larger areas of the retina. In many areas, the ILM was lacking completely. These findings are not surprising because an ILM lacking laminin α1 would likely not be bound well to the retina as this protein contains the binding sites for receptors on Müller cell endfeet [20, 21]. The preservation of the ILM in some areas suggests that other alpha chains present in the ILM, such as α5 , assist in binding this structure to the retina. Despite the differing ILM structure, the two Lama1 mutants have very similar abnormalities with regards to retinal vascular development.
Both mutants have a vascular apron around the optic nerve head at P1, suggesting that neither the Y265C mutation nor the complete loss of this protein affected endothelial cell differentiation and emigration from the optic nerve. Beginning around P3, however, it is evident that the retinal blood vessels cease to develop in the Lama1nmf223 retina and have entered the vitreous where they remain until P7-P9. These vessels, which originate within the peripapillary retina grow along the retinal surface and eventually anastomose with those of the VHP. Together, these vessels form a dense vascular network in the vitreous that persists into adulthood and is ensheathed by astrocytes. These vitreal vessels sprout and invade the retina around P10 to form the retinal vascular capillary networks. Despite their abnormal origin, the Lama1 mutant retinal capillary networks at P10 (Figure 9E) are correctly placed within the retina. Therefore, the cues guiding these diving vessels are still present. It appears, however, as though the intermediate plexus forms early in the Lama1nmf223 retina as vessels are evident in the inner plexiform layer at P10 compared to P14 in the WT retina.
The formation of the inner capillary networks further indicates that neither the Y265C point mutation in Lama1 nor the complete deletion of this protein alters the ability of endothelial cells to form blood vessels. Rather, astrocyte migration across the vitreal surface of the ILM precedes and likely causes the misguided migration of the blood vessels into the vitreous. In all retinas investigated at various ages, astrocytes were observed in the vitreous before retinal vessels traversed the ILM. In addition, only the VHP vessels were observed in the vitreous posterior to astrocytes on the vitreal aspect of the ILM. It is possible that if a normal template of astrocytes was present in the retina, the blood vessel development would also be normal. Therefore, identifying and neutralizing the factor(s) which stimulate astrocyte invasion into the vitreous may also alleviate the vascular defects in these mice. Most astrocytes from the Lama1 mutant retinas migrate towards and eventually envelop the VHP vessels. In addition, a subpopulation of these glial cells migrates from the optic nerve head directly into the vitreous along the hyaloid artery and its branches. These observations suggest that an attractant within the persistent and proliferating intravitreal vessels stimulates astrocyte migration. The previous report demonstrated that the tyrosine to cysteine mutation in the Lama1nmf223 mice significantly decreases the binding ability of laminin α1 . It is logical to hypothesize, therefore, that this mutation disrupts the strength by which laminin α1 and, consequently, the entire ILM, bind to receptors on Müller cell endfeet. As a result, the ILM may become less of a barrier for cells in the retina. Astrocytes may, therefore, respond to chemoattractants in the vitreous more easily than those in the WT retina. Astrocyte migration into the vitreous in response to these chemoattractants may create breaks in the ILM. This idea is supported by the fact that in most cases, both laminin immunohistochemistry and TEM show the ILM pushed inwardly toward the vitreous where the cells exit the retina rather than there being a clear opening in the ILM through which cells migrate (Figure 7B, 13B). Indeed, a number of proteins within the normal vitreous are known to stimulate astrocyte migration, including hyaluronic acid , endothelin-1 , TGF-beta, and PDGF-AA . Among these, PDGF-AA is the best candidate as it is known to stimulate astrocyte migration and is believed to be generated by ganglion cells in the retina [8, 26]. Furthermore, PDGF-AA overexpression by the lens stimulates astrocyte migration into the vitreous, resulting in a pattern similar to that observed in the Lama1 mutants .
Once within the vitreous, most astrocytes migrate along the vitreal surface of the ILM towards the ora serrata. This migration pattern is similar to that seen within WT retinas with the exception that it occurs on the vitreal side of the ILM. This observation indicates that the migratory cues normally present inside the retina are on the vitreal surface of the ILM in Lama1 mutants. It could also be hypothesized that proteins constituting the ILM act as guidance cues and astrocytes in the mutant retina respond to these but remain on the vitreal side once they have traversed the ILM. Yet another theory is that Müller cells, the other retinal glial cell, guide astrocyte migration. Although Müller cells may not be fully differentiated, these glial cells are in place prior to astrocyte migration into and across the retina. Furthermore, Müller cell processes in both Lama1 mutants extend into the vitreous where chemoattractants they produce could spill out. In addition, some Müller cell endfeet are properly positioned, potentially contributing to frequent contact between vitreal astrocytes and the retina. Further investigation is required to identify the stimuli that guide astrocytes across the retina and, perhaps more importantly, what cell type(s) provide these stimuli.
The association of astrocytes with hyaloid vessels occurs in other rodent mutants with persistent fetal vasculature, including Collagen 15a1/18a1 double knockouts , LIF transgenics , and the Nuc1 rat . The question arises then, do astrocytes associate with vitreal vessels as a consequence of their failure to regress or is the astrocyte association preventing their regression by stabilizing the vasculature? In the case of the Lama1 mutants, the astrocytes migrate into the vitreous and associate with hyaloid and VHP by P3, before VHP regression has normally begun. This suggests that the astrocyte ensheathment of vitreal blood vessels subsequently inhibits the vessel regression and may even stimulate their proliferation.
Astrocyte ensheathment of the fetal vasculature in vitreous also occurs in the human disease PFV [29, 30]. PFV can be a blinding disorder because the retinal vasculature is incomplete and the persistent FVV and membrane pulls on the retina causing detachment . Preretinal glial membranes are often found in patients with PFV and likely contribute to retinal detachment [29, 31, 32]. It is not uncommon for patients with PFV to develop cataracts and glaucoma as well [31, 33]. Few animal models exist for this condition and treatment involves surgery. The Lama1 mutants described herein have two hallmark features of this disease: persistence of the fetal vasculature and preretinal glial membranes, making them potential models for studying this disease.
The membranes formed by astrocytes in Lama1 mutants also resemble epiretinal membranes seen in patients with proliferative vitreoretinopathy (PVR), a complication of retinal detachment in which retinal cells and macrophages enter the vitreous. The ultrastructure of the glial-containing membrane in Lama1 mutants is similar to that described for epiretinal membranes [34, 35]. In some areas, astrocytes extend thin, delicate processes across the vitreoretinal surface and into the vitreous. These created structures similar to those which Foos called glial bridges . In others areas, numerous astrocytes overlap one another to form a dense mesh-like structure. While the glial membranes in Lama1 mutants contain mainly tightly associated astrocytes, frequent irregularly large openings are also observed (Figure 13E). The astrocytes associated with this membrane make laminin, suggesting they may also produce other extracellular matrix proteins, a key feature in PVR. Current animals models for PVR are invasive, either injection of fibroblasts into vitreous or surgical disruption of the ILM to stimulate membrane formation .
The Lama1 mutants described herein provide novel, genetic models for studying PVR and PFV. The production and expression of laminin by vitreal astrocytes in Lama1nmf223 mutants but not those in the retina indicates that they could contribute to the generation, expansion, and stabilization of the preretinal membranes. Astrocyte expression of laminin α1 and γ1 has been observed in association with glial activation during CNS disease [37, 38]. Furthermore, activated astrocytes express and secrete many cytokines which could alter the development of retinal vessels and promote membrane formation. A better understanding of how these vitreal membranes develop could help stop their formation or aid in treating them without surgery.
The present study describes a novel vascular phenotype in which vessels form initially the retina but then traverse the ILM and anastomose with hyaloid vessels. Interestingly, these vessels are able to re-enter the retina later in development and produce properly placed retinal capillary networks (Figure 1). The data presented in this report clearly demonstrates the importance of a fully functional ILM to retinal vascular development. The present study strongly suggests that mutations in LAMA1 or other ILM components in humans could cause retinal diseases such as PFV, PVR, and retinal detachment. Indeed, some Lama1Δ mutants experience retinal detachments. Finally, the observation that astrocyte ensheathment of hyaloid vessels prior to their normal regression indicates that these glial cells may contribute to the persistence of these vessels. These models could increase understanding and aid in finding treatments for PFV and PVR.
Lama1nmf223 mutants were bred and housed at the Johns Hopkins University and all experimental procedures were performed according to the Johns Hopkins University Animal Care and Use Committee standards. Homozygous matings were used to maintain this colony. C57BL/6J (B6) animals, the background strain of Lama1nmf223 , were used as controls. Mice were maintained on a 12 hr light: dark cycle with food and water ad labium. Lama1Δ mice were bred and housed under similar conditions at INSERM with approval of the INSERM animal care and use committee. Mice were genotyped as previously described . All procedures were in compliance with the ARVO statement for the use of animals for ophthalmological and vision research.
Fundus photography and fluorescein angiography
Fundus photographs of three adult Lama1nmf223 and three control mice were taken using a Micron III indirect camera (Phoenix Research Labs). Mice were anesthetized using ketamine/Xylazine and eyes dilated with atropine. Fundus photographs were taken prior to the intraperitoneal injection of 50 μl sodium fluorescein (10%; Altaire Pharmaceuticals) while the retina was in focus on the Micron III. Images were taken as the retinal vasculature was filling with fluorescein and once all vessels were filled.
Mice were euthanized by an overdose of ketamine/Xylazine for all tissue collection. A minimum of three control and three mutant mice at each age group were used for all immunohistochemical studies. Images representative of all animals have been presented herein. For flatmount analysis, eyes were fixed for 1 hr in 2% paraformaldehyde (PFA) prior to retinal dissection and 1 hr post fixation in 2% PFA. After washing, retinas were blocked for 6 hrs at 4°C with 5% goat serum in Tris buffered saline containing 1% Triton X-100 (TBST) prior to incubation in primary antibody (diluted in 2% serum in TBST) for 18 hrs at 4°C. Following TBST washes, fluorescent conjugated secondary antibodies were applied (diluted 1:300 in 5% normal mouse serum in TBST; Jackson Immunoresearch) for 3 hrs. For blood vessel labeling, FITC conjugated GS isolectin (1:200; Invitrogen; 132450) was applied at the same time as the secondary immunohistochemistry antibody. For cryosections, eyes were cryopreserved as previously described . Eight micron sections were air dried and permeabilized with cold methanol prior to blocking in 2% goat serum in TBST containing 5% BSA. Sections were incubated in primary antibody for 2 hrs, washed, and incubated in secondary antibody along with 4', 6-diamidino-2-phenylindole (DAPI; 1:1000 Invitrogen, D21490) diluted in TBST for 30 min. Primary antibodies included: rabbit anti-GFAP (1:200; Dako; Z0334), rat anti-PDGFRα (1:500; CD140a; R&D, 558774), and rabbit anti-pan laminin (1:750; Sigma; L9393), which detects multiple laminin chains. Images were captured using a Zeiss 510 Meta confocal microscope in the Wilmer Imaging Core Facility.
TEM and JB-4
Eyes for TEM and JB-4 methacrylate (Polyscience) analysis were fixed in 2.5% PFA/2% glutaraldehyde in 0.1 M cacodylate buffer and processed as previously described [4, 39, 40]. Ultrastructural analysis was performed on at least two control and two mutant eyes at each age group described. At least two animals at each age from each group were embedded for JB-4. Additional animals were not analyzed because the abnormalities noted were consistent among the different ages invested as well as observations made using immunohistochemical techniques. TEM sections stained with uranyl acetate and JB-4 sections were stained with Periodic Acid-Schiffs reagent.
fetal vasculature of vitreous
glial fibrillary acidic protein
- GS isolectin:
Griffonia simplicifolia isolectin B4
internal limiting membrane
persistent fetal vasculature
platelet-derived growth factor receptor alpha
post natal day
Tris buffered saline containing 1% Triton X-100
transmission electron microscopy
vasa hyaloidea propria
Saint-Geniez M, D'Amore PA: Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol. 2004, 48 (8-9): 1045-1058. 10.1387/ijdb.041895ms.
Dorrell MI, Aguilar E, Friedlander M: Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci. 2002, 43 (11): 3500-3510.
Dorrell MI, Friedlander M: Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog Retin Eye Res. 2006, 25 (3): 277-295. 10.1016/j.preteyeres.2006.01.001.
McLeod DS, Lutty GA, Wajer SD, Flower RW: Visualization of a developing vasculature. Microvasc Res. 1987, 33 (2): 257-269. 10.1016/0026-2862(87)90021-5.
Chan-Ling T, McLeod DS, Hughes S, Baxter L, Chu Y, Hasegawa T, Lutty GA: Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Ophthalmol Vis Sci. 2004, 45 (6): 2020-2032. 10.1167/iovs.03-1169.
Hasegawa T, McLeod DS, Bhutto IA, Prow T, Merges CA, Grebe R, Lutty GA: The embryonic human choriocapillaris develops by hemo-vasculogenesis. Dev Dyn. 2007, 236 (8): 2089-2100. 10.1002/dvdy.21231.
McLeod DS, Hasegawa T, Prow T, Merges C, Lutty G: The initial fetal human retinal vasculature develops by vasculogenesis. Dev Dyn. 2006, 235 (12): 3336-3347. 10.1002/dvdy.20988.
Fruttiger M, Calver AR, Kruger WH, Mudhar HS, Michalovich D, Takakura N, Nishikawa S, Richardson WD: PDGF mediates a neuron-astrocyte interaction in the developing retina. Neuron. 1996, 17 (6): 1117-1131. 10.1016/S0896-6273(00)80244-5.
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, et al: VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003, 161 (6): 1163-1177. 10.1083/jcb.200302047.
Weidemann A, Krohne TU, Aguilar E, Kurihara T, Takeda N, Dorrell MI, Simon MC, Haase VH, Friedlander M, Johnson RS: Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia. 2010, 58 (10): 1177-1185.
Edwards MM, Mammadova-Bach E, Alpy F, Klein A, Hicks WL, Roux M, Simon-Assmann P, Smith RS, Orend G, Wu J, et al: Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation. J Biol Chem. 2010, 285 (10): 7697-7711. 10.1074/jbc.M109.069575.
Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L, Niemela M, Ilves M, Li E, Pihlajaniemi T, et al: Lack of collagen XVIII/endostatin results in eye abnormalities. Embo J. 2002, 21 (7): 1535-1544. 10.1093/emboj/21.7.1535.
Hurskainen M, Eklund L, Hagg PO, Fruttiger M, Sormunen R, Ilves M, Pihlajaniemi T: Abnormal maturation of the retinal vasculature in type XVIII collagen/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII. Faseb J. 2005, 19 (11): 1564-1566.
Lee Y, Kameya S, Cox GA, Hsu J, Hicks W, Maddatu TP, Smith RS, Naggert JK, Peachey NS, Nishina PM: Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases. Mol Cell Neurosci. 2005, 30 (2): 160-172. 10.1016/j.mcn.2005.07.009.
Alpy F, Jivkov I, Sorokin L, Klein A, Arnold C, Huss Y, Kedinger M, Simon-Assmann P, Lefebvre O: Generation of a conditionally null allele of the laminin alpha1 gene. Genesis. 2005, 43 (2): 59-70. 10.1002/gene.20154.
Miner JH, Yurchenco PD: Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004, 20: 255-284. 10.1146/annurev.cellbio.20.010403.094555.
Yurchenco PD, Quan Y, Colognato H, Mathus T, Harrison D, Yamada Y, O'Rear JJ: The alpha chain of laminin-1 is independently secreted and drives secretion of its beta- and gamma-chain partners. Proc Natl Acad Sci USA. 1997, 94 (19): 10189-10194. 10.1073/pnas.94.19.10189.
De Arcangelis A, Neuville P, Boukamel R, Lefebvre O, Kedinger M, Simon-Assmann P: Inhibition of laminin alpha 1-chain expression leads to alteration of basement membrane assembly and cell differentiation. J Cell Biol. 1996, 133 (2): 417-430. 10.1083/jcb.133.2.417.
Colognato H, Yurchenco PD: Form and function: the laminin family of heterotrimers. Dev Dyn. 2000, 218 (2): 213-234. 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R.
Guidry C, Bradley KM, King JL: Tractional force generation by human muller cells: growth factor responsiveness and integrin receptor involvement. Invest Ophthalmol Vis Sci. 2003, 44 (3): 1355-1363. 10.1167/iovs.02-0046.
Koulen P, Blank M, Kroger S: Differential distribution of beta-dystroglycan in rabbit and rat retina. J Neurosci Res. 1998, 51 (6): 735-747. 10.1002/(SICI)1097-4547(19980315)51:6<735::AID-JNR7>3.0.CO;2-C.
Miner JH, Li C, Mudd JL, Go G, Sutherland AE: Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation. Development. 2004, 131 (10): 2247-2256. 10.1242/dev.01112.
Bystrom B, Virtanen I, Rousselle P, Gullberg D, Pedrosa-Domellof F: Distribution of laminins in the developing human eye. Invest Ophthalmol Vis Sci. 2006, 47 (3): 777-785. 10.1167/iovs.05-0367.
Bourguignon LY, Gilad E, Peyrollier K, Brightman A, Swanson RA: Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes. J Neurochem. 2007, 101 (4): 1002-1017. 10.1111/j.1471-4159.2007.04485.x.
Murphy JA, Archibald ML, Chauhan BC: The role of endothelin-1 and its receptors in optic nerve head astrocyte proliferation. Br J Ophthalmol. 2010, 94 (9): 1233-1238. 10.1136/bjo.2009.172098.
Reneker LW, Overbeek PA: Lens-specific expression of PDGF-A in transgenic mice results in retinal astrocytic hamartomas. Invest Ophthalmol Vis Sci. 1996, 37 (12): 2455-2466.
Ash J, McLeod DS, Lutty GA: Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eye. Mol Vis. 2005, 11: 298-308.
Sinha D, Klise A, Sergeev Y, Hose S, Bhutto IA, Hackler L, Malpic-Llanos T, Samtani S, Grebe R, Goldberg MF, et al: betaA3/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development. Mol Cell Neurosci. 2008, 37 (1): 85-95. 10.1016/j.mcn.2007.08.016.
Manschot WA: Persistent hyperplastic primary vitreous; special reference to preretinal glial tissue as a pathological characteristic and to the development of the primary vitreous. AMA Arch Ophthalmol. 1958, 59 (2): 188-203.
Zhang C, Gehlbach P, Gongora C, Cano M, Fariss R, Hose S, Nath A, Green WR, Goldberg MF, Zigler JS, et al: A potential role for beta- and gamma-crystallins in the vascular remodeling of the eye. Dev Dyn. 2005, 234 (1): 36-47. 10.1002/dvdy.20494.
Goldberg MF: Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 1997, 124 (5): 587-626.
Rubinstein K: Posterior hyperplastic primary vitreous. Br J Ophthalmol. 1980, 64 (2): 105-111. 10.1136/bjo.64.2.105.
Shastry BS: Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Experiment Ophthalmol. 2009, 37 (9): 884-890. 10.1111/j.1442-9071.2009.02150.x.
Foos RY: Vitreoretinal juncture; epiretinal membranes and vitreous. Invest Ophthalmol Vis Sci. 1977, 16 (5): 416-422.
Messmer EM, Heidenkummer HP, Kampik A: Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol. 1998, 236 (4): 248-254. 10.1007/s004170050072.
Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ, Hinton DR: In vivo models of proliferative vitreoretinopathy. Nat Protoc. 2007, 2 (1): 67-77. 10.1038/nprot.2007.4.
Liesi P, Kauppila T: Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar. Exp Neurol. 2002, 173 (1): 31-45. 10.1006/exnr.2001.7800.
Wiksten M, Vaananen A, Liesi P: Selective overexpression of gamma1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology. J Neurosci Res. 2007, 85 (9): 2045-2058. 10.1002/jnr.21314.
Baba T, Bhutto IA, Merges C, Grebe R, Emmert D, McLeod DS, Armstrong D, Lutty GA: A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection. Am J Pathol. 2010, 176 (6): 3085-3097. 10.2353/ajpath.2010.090989.
Baba T, Grebe R, Hasegawa T, Bhutto I, Merges C, McLeod DS, Lutty GA: Maturation of the fetal human choriocapillaris. Invest Ophthalmol Vis Sci. 2009, 50 (7): 3503-3511. 10.1167/iovs.08-2614.
Acknowledgements and Funding
We would like to acknowledge support from the National Institute of Health [EY016551 (GAL) and Wilmer Core Grant (EY01765)], Research to Prevent Blindness (Unrestricted funds to Wilmer), and Ligue Contre Le Cancer, CCIR-GE (OL). We thank the Raab Family Foundation and the Wilmer Pooled Professor Fund for purchasing the Micron III Imaging System. We also wish to thank Annick Klein for technical assistance.
ME participated in designing the study, performed the experiments and drafted the manuscript. DSM constructed figures for the manuscript and helped in drafting the manuscript. RG performed electron microscopy. CH maintained and collected tissue from the Lama1Δ mice. OL developed the Lama1Δ mice and assisted in revising the manuscript. GL designed the study, assisted with data analysis and drafted the manuscript. All authors have read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Figure S1. Ultrastructure of the P1 Lama1Δ eyes. (A) The ILM in the Lama1Δ mutant mouse is thin and fragmented. (B) Astrocytes (arrows) could be observed on the vitreal side of the ILM. Scale bars indicate (A: 1 μm and B: 500 nm). (TIFF 2 MB)
Additional file 2: Figure S2. Lama1Δ retinas lack retinal vessels. Retinal vessels, labeled with GS isolectin (green), and astrocytes, labeled with GFAP (red), extend to the periphery of the control retina (A) but are completely absent from the Lama1Δ mutant (B) at P7. Scale bars indicate 100 μm. (TIFF 4 MB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Edwards, M.M., McLeod, D.S., Grebe, R. et al. Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice. BMC Dev Biol 11, 60 (2011). https://doi.org/10.1186/1471-213X-11-60